HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Takeshita Selected Research

bis(1- N- oxide- pyridine- 2- thiolato)oxovanadium(IV)

6/2001Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Takeshita Research Topics

Disease

4Atherosclerosis
03/2001 - 01/2000
3Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
03/2005 - 02/2000
3Sepsis (Septicemia)
08/2001 - 02/2000
2Hypersensitivity (Allergy)
10/2009 - 06/2000
2Inflammation (Inflammations)
10/2009 - 03/2002
2Insulin Resistance
05/2007 - 06/2001
2Necrosis
05/2007 - 02/2000
2Virus Diseases (Viral Diseases)
11/2001 - 02/2000
2Atherosclerotic Plaque (Atheroma)
03/2001 - 01/2001
2Osteolysis
12/2000 - 02/2000
1Chronic Kidney Failure (Chronic Renal Failure)
07/2020
1Diabetes Mellitus
07/2020
1Acute Kidney Injury (Acute Renal Failure)
07/2020
1Hemorrhage
01/2018
1Vitamin K Deficiency
01/2018
1Respiratory Tract Diseases (Respiratory Tract Disease)
10/2009
1Autoimmune Diseases (Autoimmune Disease)
03/2002
1Motion Sickness (Airsickness)
12/2001
1Ischemia
11/2001
1Essential Hypertension
11/2001
1Bacterial Infections (Bacterial Infection)
11/2001
1Pathologic Neovascularization
11/2001
1Angina Pectoris
10/2001
1Arteritis
08/2001
1Type 2 Diabetes Mellitus (MODY)
06/2001
1Obesity
06/2001
1Glucose Intolerance
06/2001
1Myocardial Infarction
04/2001
1Vascular Remodeling
03/2001
1Vascular System Injuries
03/2001
1Atrophy
10/2000
1Body Weight (Weight, Body)
10/2000
1Seizures (Absence Seizure)
08/2000
1Pain (Aches)
08/2000
1Cavernous Hemangioma (Cavernous Angioma)
08/2000
1Bone Resorption
02/2000
1Communicable Diseases (Infectious Diseases)
02/2000
1Gram-Negative Bacterial Infections
02/2000
1Parasitic Diseases (Parasitic Disease)
01/2000

Drug/Important Bio-Agent (IBA)

3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2001 - 02/2000
3Superoxides (Superoxide)IBA
01/2001 - 01/2000
2Glucose (Dextrose)FDA LinkGeneric
05/2007 - 06/2001
2DNA (Deoxyribonucleic Acid)IBA
11/2001 - 01/2000
2Matrix Metalloproteinases (MMPs)IBA
08/2001 - 03/2001
2Interferon-gamma (Interferon, gamma)IBA
06/2000 - 02/2000
2CytokinesIBA
02/2000 - 02/2000
1Biomarkers (Surrogate Marker)IBA
07/2020
1Vitamin KFDA Link
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1hepaplastinIBA
01/2018
1AllergensIBA
10/2009
1Immunoglobulin E (IgE)IBA
10/2009
1CD55 Antigens (Decay Accelerating Factor)IBA
10/2009
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
05/2007
12,4-thiazolidinedione (thiazolidinedione)IBA
05/2007
1Rosiglitazone (Avandia)FDA Link
05/2007
1Pioglitazone (Actos)FDA Link
05/2007
1PPAR-gamma AgonistsIBA
05/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2005
1EndostatinsIBA
03/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2005
1Intravenous Immunoglobulins (IVIG)FDA Link
03/2002
1tandospironeIBA
12/2001
1Serotonin 5-HT1 Receptor AgonistsIBA
12/2001
1Antihypertensive Agents (Antihypertensives)IBA
11/2001
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2001
1PerindoprilFDA LinkGeneric
11/2001
1AnnexinsIBA
11/2001
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2001
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2001
1Messenger RNA (mRNA)IBA
08/2001
1GelatinasesIBA
08/2001
1Insulin (Novolin)FDA Link
06/2001
1Vanadates (Orthovanadate)IBA
06/2001
1Protein Tyrosine PhosphatasesIBA
06/2001
1bis(1- N- oxide- pyridine- 2- thiolato)oxovanadium(IV)IBA
06/2001
1bis(1- oxy- 2- pyridinethiolato)oxovanadium(IV)IBA
06/2001
1Glycoproteins (Glycoprotein)IBA
04/2001
1Fibrinogen (Factor I)FDA Link
04/2001
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2001
1oxidized low density lipoproteinIBA
01/2001
1CopperIBA
01/2001
1CholesterolIBA
01/2001
1FluvastatinFDA Link
01/2001
1LipopolysaccharidesIBA
11/2000
1Monoclonal AntibodiesIBA
11/2000
1Reserpine (Serpasil)FDA Link
10/2000
1Opioid Analgesics (Opioids)IBA
08/2000
1CPG-oligonucleotideIBA
06/2000
1Anti-Allergic Agents (Antiallergic Agents)IBA
06/2000
1Macrophage Colony-Stimulating FactorIBA
02/2000
1RANK LigandIBA
02/2000
1Interleukin-1beta (Interleukin 1 beta)IBA
02/2000
1Lipopolysaccharide ReceptorsIBA
02/2000
1SteroidsIBA
01/2000

Therapy/Procedure

2Therapeutics
10/2001 - 01/2000
1Hip Replacement Arthroplasty (Total Hip Replacement)
07/2020
1Aftercare (After-Treatment)
06/2001
1Electrodes (Electrode)
08/2000
1Analgesia
08/2000